Skip to main content

Table 1 Patients and disease characteristics

From: Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

Characteristics

Number of patients

Median age : years (range)

60 (51–66)

Gender

 

- Male

5

- Female

1

Performans Status (PS)

 

- 0

6

- >0

0

Disease stage

 

- ≤2

0

- >3

6

Number of previous chemotherapies

 

- 1

1

- 2

3

- 3

2

Disease status at transplantation

 

- Complete response

3

- Partial response

3

PET-CT before transplantation

 

- Negative

3

- Positive

3

Median time between diagnosis or relapse and ASCT (months) (range)

8.5 (7–12)